SmartMoney Full Banner 468 x 60

Enter your email address:

Delivered by FeedBurner

>> Bookmark This Site!


Search Site


Recent Posts

  • Featured Sites

  • Stock Blogs


    Stock News

    « Previous Entries

    Shorts Selling Spreading Outside of Financials

    Wednesday, November 12th, 2008

    Short sellers are still betting that financial shares will fall but they have boldly moved into shares of companies which are considered healthy, those with both good balance sheets and relatively strong earnings prospects.Data is as of the end of October. The short interest in AIG (AIG) rose 44% to 135.7 million shares. Short interest [...]

    House Passes Bill; Stock Market Reverses

    Friday, October 3rd, 2008

    After Congress unexpectedly prevented the bailout bill from passing last week, the Dow shed 700 points. In what could be a grim omen of things to come, today’s passage of a revised bill did not assuage investors, with the Dow falling 157 points and the other major indexes taking major losses after an early rally [...]

    Wall Street Execs Fight for Bonuses

    Tuesday, September 23rd, 2008

    ABC News reports: In 2007, Wall Street’s five biggest firms — Bear Stearns, Goldman Sachs, Lehman Brothers, Merrill Lynch, and Morgan Stanley — paid a record $39 billion in bonuses to themselves. That’s $10 billion more than the $29 billion loan taxpayers are making to J.P. Morgan to save Bear Stearns. Those 2007 bonuses were [...]

    Crox Shares Take A Beating; Outlook Grim

    Friday, August 1st, 2008

    Shoe company Crocs Inc. lowered its second-quarter guidance and projected a weak third quarter late Thursday, sending shares plummeting after the market closed. The company said it expects earnings per share of 3 cents to 7 cents for the second quarter, significantly lower than the 42 cents to 47 cents per share previously expected. The [...]

    Ebay Reconsidering Skype Purchase

    Saturday, April 19th, 2008

    Ebay, Inc. (EBAY) is currently reconsidering it’s ill-advised $3.1 billion acquisition of Skype after the auction company has continually failed to find ways to find synergies between Skype and it’s core e-commerce business. “What we’re testing this year are the synergies,” Mr Donahoe told the Financial Times this week after Ebay reported its latest earnings. [...]

    Best Buy, Netflix to Embrace Blue Ray

    Tuesday, February 12th, 2008

    It looks like the curtain is about to fall on HD DVD’s as Blu-ray wins another round in the DVD format wars: Best Buy Co Inc (BBY), the largest U.S. consumer electronics chain, said on Monday it will recommend that consumers choose Sony Corp’s Blu-ray high-definition video format. The decision gives Sony yet another victory [...]

    Facebook Hires New CFO – IPO Coming?

    Wednesday, July 25th, 2007

    Facebook’s rejection of huge offers from big name companies such as Yahoo and Viacom and their recent flurry of finance related job hires points to a possible IPO filing in the works. The latest headlines report former YouTube Chief Financial Officer Gideon Yu as Facebook’s new CFO, replacing prior finance chief Michael Sheridan, in the [...]

    Unaccounted iPhone Fees for Apple?

    Tuesday, July 24th, 2007

    I came across this interesting article over at which claims that there are huge potential iPhone fees that are not accounted for in Apple’s stock price. People close to the companies tell that AT&T is paying Apple a bounty of between $150 and $200 per phone — plus $9 a month per phone [...]

    Investors Blog Network Festival #9

    Tuesday, June 19th, 2007

    The 9th Investors Blog Network festival is up over at Some posts I found interesting: Mutual Funds- What You Need To Know Stock Market Technical Analysis Versus Fundamental Analysis, In Pictures Is Qualcomm decline a buying opportunity? Check out the rest of the articles here.

    DNDN to Raise $75 Million

    Monday, June 4th, 2007

    In our latest episode of the Dendreon (DNDN) saga, it appears that the company is looking for additional financing, possibly for additional clinical trials for it’s cancer drug, Provenge. I had speculated previously that DNDN may be looking for additional sources of funding after it’s stock price took a heavy beating following it’s failure to obtain [...]

    « Previous Entries